Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition With Beta In-Stent Trial - 28/08/11

Kazuyuki Shirai, MD ^a, Alexandra J. Lansky, MD ^{a, ⁎} , Gary S. Mintz, MD ^a, Costantino O. Costantini, MD ^a, Ecatarina Cristea, MD ^a, Martin Fahy, MSc ^a, Lynn Vandertie, MS ^e, Alan Yeung, MD ^c, Albert E. Raizner, MD ^d, Ron Waksman, MD ^b, Martin B. Leon, MD ^a

^a Cardiovascular Research Foundation at Lenox Hill Hospital, New York, New York, USA 

^b Department of Internal Medicine (Cardiology Division), Washington Hospital Center, Washington, DC, USA 

^c Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California, USA 

^d Methodist Hospital, Baylor College of Medicine, Houston, Texas, USA 

^e Guidant Corporation, Santa Clara, California, USA This study was funded in part by unrestricted education grant from Guidant Corporation, Santa Clara, California. 

^*Dr. Lansky’s address is: Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, New York 10022, USA.